 |
bevacizumab |
|---|---|
| Trade Name | Avastin |
| Orphan Indication | Malignant pleural mesothelioma |
| USA Market Approval | USA |
| USA Designation Date | 2016-01-27 00:00:00 |
| Sponsor | Genentech, Inc.;1 DNA Way;South San Francisco, California, 94080 |
| |
bevacizumab |
|---|---|
| Trade Name | Avastin |
| Orphan Indication | Malignant pleural mesothelioma |
| USA Market Approval | USA |
| USA Designation Date | 2016-01-27 00:00:00 |
| Sponsor | Genentech, Inc.;1 DNA Way;South San Francisco, California, 94080 |